Jonathan J. Havel
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Immune Cell Function and Interaction, T-cell and B-cell Immunology
Most-Cited Works
- → Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer(2015)7,864 cited
- → Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab(2017)2,514 cited
- → The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy(2019)2,306 cited
- → The head and neck cancer immune landscape and its immunotherapeutic implications(2016)780 cited
- → Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response(2019)567 cited
- → Immunogenic neoantigens derived from gene fusions stimulate T cell responses(2019)377 cited
- → Non-cell-autonomous cancer progression from chromosomal instability(2023)255 cited
- → The role of neoantigens in response to immune checkpoint blockade(2016)184 cited
- → Commensal bacteria stimulate antitumor responses via T cell cross-reactivity(2020)167 cited
- → Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy(2016)155 cited